Pharmaceutical Product & Preparations Manufacturing in France - Market Size, Industry Analysis, Trends and Forecasts (2025-2029)

Pharmaceutical Product & Preparations Manufacturing in France industry analysis

The pharmaceutical product and preparations manufacturing industry has experienced volatile, albeit positive, development in recent years. The COVID-19 outbreak in 2020 skyrocketed the industry’s importance, with many manufacturers rushing to develop and patent COVID-19 vaccines and other related tests. Spiking hospital admissions during the height of the pandemic also heightened demand for various pharmaceutical products. Following the pandemic, chemical goods and production costs have become massively more expensive in the wake of the energy crisis in 2022. The Russian invasion of Ukraine significantly disrupted global energy markets. In combination with a surge in energy demand following the pandemic, energy prices increased as economies began to recover. The increased costs could not be passed on in full and had a negative impact on earnings as well as profit. Still, revenue is expected to climb at a compound annual rate of 2.4% over the five years through 2025 to reach €54.9 billion, including an estimated increase of 1.3% in 2025. Although EU pharma manufacturers are investing heavily in new treatment research and development, boosting industry growth, they are also facing intense competition from overseas suppliers, particularly from China and India, when it comes to selling intensive-care medical products.

Trends and Insights

• The European pharmaceutical manufacturing industry is on an upward trajectory. An ageing population and increased healthcare expenditure are leading to rising demand for pharmaceuticals.
• Geopolitical events have had a direct impact on the pharmaceutical industry. The Russia-Ukraine war and other geopolitical events are driving demand for specific medicines and medical products, like iodine and antisera.
• The European pharmaceutical industry exhibits a significant level of concentration. A few major manufacturers dominate the market, highlighting the challenge for smaller companies to compete effectively.